Authors: Gjeruldsen, S Abdelnoor, M Opjordsmoen, S Myrvang, B

Citation: S. Gjeruldsen et al., Death rates and causes of death in cohorts of serum hepatitis patients followed up for more than 20 years, EPIDEM INFE, 126(1), 2001, pp. 89-96

Authors: Mork, C Kalgaard, OM Myrvang, B Kvernebo, K

Citation: C. Mork et al., Erythromelalgia in a patient with AIDS, J EUR A D V, 14(6), 2000, pp. 498-500

Authors: Liestol, K Kvittingen, EA Rootwelt, H Dunlop, O Goplen, AK Pedersen, JC Brorson, SH Borresen-Dale, AL Myrvang, B Maehlen, J

Citation: K. Liestol et al., Association between apolipoprotein E genotypes and cancer risk in patientswith acquired immunodeficiency syndrome, CANCER DET, 24(5), 2000, pp. 496-499

Authors: Jensenius, M Hasle, G Henriksen, AZ Vene, S Raoult, D Bruu, AL Myrvang, B

Citation: M. Jensenius et al., African tick-bite fever imported into Norway: Presentation of 8 cases, SC J IN DIS, 31(2), 1999, pp. 131-133

Authors: Jensenius, M Ronning, EJ Blystad, H Bjorneklett, A Hellum, KB Bucher, A Haheim, LL Myrvang, B

Citation: M. Jensenius et al., Low frequency of complications in imported falciparum malaria: A review of222 cases in south-eastern Norway, SC J IN DIS, 31(1), 1999, pp. 73-78

Authors: Bell, H Hellum, K Harthug, S Myrvang, B Ritland, S Maeland, A von der Lippe, B Bjoro, K Skaug, K Gutigard, BG Raknerud, N Simmonds, P

Citation: H. Bell et al., Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a, SC J GASTR, 34(2), 1999, pp. 194-198